ATE116662T1 - Delipidiertes polysaccharid, verfahren zur herstellung und zusammensetungen welche dieses enthalten. - Google Patents

Delipidiertes polysaccharid, verfahren zur herstellung und zusammensetungen welche dieses enthalten.

Info

Publication number
ATE116662T1
ATE116662T1 AT91400648T AT91400648T ATE116662T1 AT E116662 T1 ATE116662 T1 AT E116662T1 AT 91400648 T AT91400648 T AT 91400648T AT 91400648 T AT91400648 T AT 91400648T AT E116662 T1 ATE116662 T1 AT E116662T1
Authority
AT
Austria
Prior art keywords
polysaccharide
compound
delipidated
weight
producing
Prior art date
Application number
AT91400648T
Other languages
English (en)
Inventor
Hans Lotissement Les Cret Binz
D Hinterland Lucien Dussourd
Gerard Normier
Pape Alain Le
Michel Favaron
Souhail Delassan
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE116662T1 publication Critical patent/ATE116662T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91400648T 1990-03-08 1991-03-08 Delipidiertes polysaccharid, verfahren zur herstellung und zusammensetungen welche dieses enthalten. ATE116662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002957A FR2659351B1 (fr) 1990-03-08 1990-03-08 Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.

Publications (1)

Publication Number Publication Date
ATE116662T1 true ATE116662T1 (de) 1995-01-15

Family

ID=9394527

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91400648T ATE116662T1 (de) 1990-03-08 1991-03-08 Delipidiertes polysaccharid, verfahren zur herstellung und zusammensetungen welche dieses enthalten.

Country Status (11)

Country Link
US (1) US5601799A (de)
EP (1) EP0446143B1 (de)
JP (1) JPH04220401A (de)
AT (1) ATE116662T1 (de)
AU (1) AU646842B2 (de)
CA (1) CA2037741A1 (de)
DE (1) DE69106406T2 (de)
DK (1) DK0446143T3 (de)
ES (1) ES2068527T3 (de)
FR (1) FR2659351B1 (de)
GR (1) GR3015538T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5406950A (en) * 1993-12-23 1995-04-18 Mallinckrodt Medical, Inc. Inhalable contrast agent
FR2717483B1 (fr) * 1994-03-16 1996-06-07 Pf Medicament Préparation d'un composé polysaccharidique D25 délipidé et purifié et composition injectable en comportant.
FR2734160B1 (fr) * 1995-05-18 1997-08-01 Pf Medicament Utilisation d'un compose comportant une structure glycanique pour le blocage d'anticorps et procede d'obtention d'un tel produit
CA2279147C (en) 1999-07-29 2003-02-18 Graminia Developments Ltd. Liquid for producing marker vapour, a method of producing marker vapour and a method of inspection with marker vapour
CA2438448C (en) * 2003-08-27 2008-11-18 Quality Fabricating & Machining Ltd. Leak detector
US9820986B2 (en) 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
RU2401839C2 (ru) 2006-02-14 2010-10-20 Кусиро Индастриал Текнолоджи Сентер Способ получения протеогликана
JP6688498B2 (ja) * 2014-10-16 2020-04-28 地方独立行政法人青森県産業技術センター プロテオグリカンの分解方法及び分解物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285936A (en) * 1979-12-10 1981-08-25 The United States Of America As Represented By The Secretary Of The Army Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
DE3224788A1 (de) * 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
US4873088A (en) * 1983-09-06 1989-10-10 Liposome Technology, Inc. Liposome drug delivery method and composition
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
FR2650506B1 (fr) * 1989-07-11 1991-11-08 Roussel Uclaf Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament

Also Published As

Publication number Publication date
EP0446143B1 (de) 1995-01-04
ES2068527T3 (es) 1995-04-16
DK0446143T3 (da) 1995-03-13
GR3015538T3 (en) 1995-06-30
EP0446143A3 (en) 1992-02-12
DE69106406T2 (de) 1995-05-24
AU7263791A (en) 1991-09-12
AU646842B2 (en) 1994-03-10
DE69106406D1 (de) 1995-02-16
FR2659351B1 (fr) 1994-12-02
FR2659351A1 (fr) 1991-09-13
JPH04220401A (ja) 1992-08-11
EP0446143A2 (de) 1991-09-11
CA2037741A1 (fr) 1991-09-09
US5601799A (en) 1997-02-11

Similar Documents

Publication Publication Date Title
DE68929281D1 (de) Verfahren zur Herstellung einer modifizierten Stärke mit verbesserten emulgierenden Eigenschaften
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
EP1787532A3 (de) Gemische von mikrobiellen Ölen und deren Verwendungen
DE3853051D1 (de) Verfahren zur Herstellung von Polyphenylensulfid-Zusammensetzungen.
DE3887247D1 (de) Feste unverdauliche fettähnliche Verbindungen.
ATE38841T1 (de) Geformter artikel aus hyaluronsaeure und verfahren zu seiner herstellung.
KR880010763A (ko) 심장 및 심장혈관계에 작용하는 약학조성물 및 그의 제조방법
DE3482479D1 (de) Ultrareine hyaluronsaeure und verfahren zu deren herstellung.
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
DE69106406D1 (de) Delipidiertes Polysaccharid, Verfahren zur Herstellung und Zusammensetungen welche dieses enthalten.
MY105324A (en) Wet-etch process and compositon
DE69105301D1 (de) Verwendung eines Pyrodextrinhydrolysates zur Herstellung einer Nahrungsmittelzusammensetzung zur Verbesserung der Serumlipidzusammensetzung.
DK0394803T3 (da) Biologisk nedbrydelig formstofmaterialer
PT93792A (pt) Processo para a preparacao e emprego de uma emulsao aquosa a base de poliolefinas enxertadas nomeadamente nas composicoes de aparelho
PT79648A (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
BG98470A (bg) Метод за превръщане на липид-съдържащи бактериални капсуловани полизахариди в свободни от липид полизахариди
ATE139672T1 (de) Neue feste unverdauliche fettähnliche verbindungen und diese enthaltende nahrungsmittelzusammensetzungen
DE69111951D1 (de) Mayonnaise mit niedrigem Fettgehalt und Verfahren zur Herstellung.
ATE127488T1 (de) Polyester-mischung, ihre herstellung und verwendung.
DE69231020D1 (de) Succinoglycan enthaltende Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Anwendungen
SE8800989D0 (sv) Dietary composition and process for preparing same
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
ATE122051T1 (de) Verfahren zur herstellung von künstlichen n- verbundenen glycoconjugaten.
ATE136917T1 (de) Gleitmittel für thermoplastische zusammensetzungen, diese enthaltende zusammensetzungen, verfahren zur herstellung von flaschen
DE69118879D1 (de) Ester und diese enthaltende flüssigkeiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee